Sáez-Llorens, X., deAntonio, R., López-Medina, E., López, P., Masuda, T., Mendelman, P. M., . . . Borkowski, A. Safety and immunogenicity of a bivalent norovirus vaccine candidate in infants from 6 weeks to 5 months of age: A phase 2, randomized, double-blind trial. Taylor & Francis Group.
Chicago Style (17th ed.) CitationSáez-Llorens, Xavier, Rodrigo deAntonio, Eduardo López-Medina, Pío López, Taisei Masuda, Paul M. Mendelman, Jim Sherwood, Frank Baehner, and Astrid Borkowski. Safety and Immunogenicity of a Bivalent Norovirus Vaccine Candidate in Infants from 6 Weeks to 5 Months of Age: A Phase 2, Randomized, Double-blind Trial. Taylor & Francis Group.
MLA (9th ed.) CitationSáez-Llorens, Xavier, et al. Safety and Immunogenicity of a Bivalent Norovirus Vaccine Candidate in Infants from 6 Weeks to 5 Months of Age: A Phase 2, Randomized, Double-blind Trial. Taylor & Francis Group.